Response to case report: Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy

• I. J. Pouliquen,
• P. Howarth,
• D. Austin,
• G. Gunn,
• E. Meyer,
• R. G. Price,
• E. Bradford

Affiliations

I. J. Pouliquen

Clinical Pharmacology Modelling & Simulation, GlaxoSmithKline

P. Howarth

Respiratory Franchise, GlaxoSmithKline

D. Austin

Clinical Pharmacology Modelling & Simulation, GlaxoSmithKline

G. Gunn

Immunogenicity and Clinical Immunology, GlaxoSmithKline

E. Meyer

Immunogenicity and Clinical Immunology, GlaxoSmithKline

R. G. Price

Clinical Statistics, GlaxoSmithKline

E. Bradford

Respiratory Therapeutic Area, GlaxoSmithKline